Tag: Clinical Trials

Survival benefits disappear when only high-quality studies are pooled and with adjustment for potential publication bias

Statistically significant survival gains observed for patients with solid tumors assigned to experimental group

One in five patients with cancer participate in any cancer-related trial, including biorepository, registry, genetic, and quality-of-life studies

A total of 203 images were shared depicting 60 patients, for an overall sharing rate of 0.1 percent

Underrepresentation seen among Asian and Hispanic women for all cancer sites, with variance for Black women by cancer site

Some gains seen in racial/ethnic and geographic diversity; more older patients also enrolled

Median PFS, OS similar for Black and White patients receiving first- or second-generation androgen receptor pathway inhibitors

Blacks and other race subgroups have higher multiple myeloma trial ineligibility rates compared with Whites

Asian American, Black, and Hispanic populations underrepresented compared with U.S. population demographics

Outcomes worse for Black versus White patients enrolled in clinical trials that minimize access to care, socioeconomic status confounders